A Randomized, Double-Blinded, Placebo-Controlled, Phase II Inhaled Interferon Gamma-1b and Antimycobacterials to Treat Pulmonary Mycobacterium Avium Complex Infections
PHASE2CompletedINTERVENTIONAL
Enrollment
20
Participants
Timeline
Start Date
July 31, 2001
Study Completion Date
June 30, 2002
Conditions
Mycobacterium Avium-Intracellulare Infection
Interventions
DRUG
Interferon Gamma for Aerosol
Trial Locations (1)
20892
National Institute of Allergy and Infectious Diseases (NIAID), Bethesda
All Listed Sponsors
lead
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
NCT00021567 - A Randomized, Double-Blinded, Placebo-Controlled, Phase II Inhaled Interferon Gamma-1b and Antimycobacterials to Treat Pulmonary Mycobacterium Avium Complex Infections | Biotech Hunter | Biotech Hunter